Skip to content
Search

Latest Stories

Walgreens reviving talks to offload £7 billion UK Boots pharmacy chain

Walgreens reviving talks to offload £7 billion UK Boots pharmacy chain
Photo: iStock

The company earlier scrapped its plans to sell the UK high street pharmacy chain after failing to secure the desired valuation for the business

Walgreens Boots Alliance is in discussions about ways to separate its UK-based Boots drugstore chain, and it is considering the possibility of an initial public offering (IPO) in London, Bloomberg News reported on Tuesday.


People familiar with the matter told the publication that the drugstore chain could be valued at about £7 billion ($8.8 billion) in a deal, but the sale process could only start next year at the earliest.

The US company invited bids for Boots last year but scrapped the plan in June 2022 after failing to secure the desired valuation for the business due to a turbulent credit market.

As per the report, Walgreens may invite fresh offers for the UK high street pharmacy chain, but deliberations are still at a preliminary stage and it’s not certain they will lead to a transaction.

Until 2022, Boots has a network of more than 2,000 stores across the UK and Ireland including local pharmacies and large health and beauty shops, and employs over 52,000 people.

Earlier this year, the company announced plans to shut down 300 stores in the country in the next 12 months, mostly those in close proximity to other outlets, in a bid to increase ‘efficiency’.

The high street retailer has already shut a number of stores this year including its branches in Mudge Way, Plymouth; Mount Pleasant Road, Exeter;  Low Moor Road, Kirkby, Ashfield; and Gorleston High Street, Great Yarmouth.

Boots stores that would be shut down in the near future include Cambridge Road, Stanstead (January 6); Northdown Road, Margate, Kent (January 20); Wood Street, Swindon (February 9); and Front Street, Prudhoe (TBC).

Walgreens reached a deal in November to transfer its £4.8 billion ($6 billion) pension plan to financial services company Legal & General Group Plc.

The pension scheme is seen as a stumbling block that had complicated previous efforts to sale the business.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less